NIH-funded research NIH-funded research

Improving treatment retention for pregnant individuals with substance use disorders

Official title: Substance Use in Pregnant People - Optimizing Retention in Treatment by Maximizing Opportunities for Management (SUPPORT-MOM)

Funded at Washington University · NIH-11058100 · Data updated 2026-11-12

This study is looking for ways to help pregnant people who are dealing with substance use issues stick to their treatment by offering rewards for staying on track, and it aims to see if this approach can improve their health and safety during pregnancy, especially for those from underserved communities.

More Substance Use research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionWashington University
NIH-funded
Lab location1 site (Saint Louis, United States)
Project startSeptember 30, 2024
Project endAugust 31, 2026
Funding year2024
Award (this year)$936,934
NIH project number1R61DA062321-01
Project IDNIH-11058100 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are pregnant individuals experiencing substance use disorders who are seeking treatment.

Less likely to help

Patients who are not pregnant or those who do not have substance use disorders may not benefit from this research.

What this research studies

This research focuses on enhancing treatment retention for pregnant individuals struggling with substance use disorders (SUD). It aims to implement a strategy called contingency management, which provides incentives for patients to adhere to their treatment plans. By conducting a randomized control trial at the Clinic for Acceptance, Recovery, and Empowerment (CARE) in Pregnancy, the study seeks to evaluate the effectiveness of this approach in reducing maternal morbidity and overdose risk. The research also addresses the impact of social determinants of health on treatment outcomes, particularly for historically marginalized populations.

Why it matters

Potential benefit: If successful, this research could lead to improved treatment retention and better health outcomes for pregnant individuals with substance use disorders.

How similar studies have gone: Previous research has shown that contingency management can be effective for tobacco cessation in pregnant populations, but its application for other substance use disorders is less established.

Where this research is happening

  • Washington University
    Saint Louis, United States
    Active

Researchers

  • Principal investigator: Kelly, Jeannie Chen — Washington University
  • Study coordinator: Kelly, Jeannie Chen

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.